Your browser doesn't support javascript.
loading
Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2.
Yu, Krystle Kq; Fischinger, Stephanie; Smith, Malisa T; Atyeo, Caroline; Cizmeci, Deniz; Wolf, Caitlin R; Layton, Erik D; Logue, Jennifer K; Aguilar, Melissa S; Shuey, Kiel; Loos, Carolin; Yu, Jingyou; Franko, Nicholas; Choi, Robert Y; Wald, Anna; Barouch, Dan H; Koelle, David M; Lauffenburger, Douglas; Chu, Helen Y; Alter, Galit; Seshadri, Chetan.
Affiliation
  • Yu KK; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Fischinger S; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Smith MT; PhD program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.
  • Atyeo C; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Cizmeci D; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Wolf CR; PhD program in Virology, Division of Medical Sciences, Harvard University, Boston, Massachusetts, USA.
  • Layton ED; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Logue JK; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Aguilar MS; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Shuey K; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Loos C; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Yu J; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Franko N; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Choi RY; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
  • Wald A; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Koelle DM; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Lauffenburger D; Providence Medical Group, Everett, Washington, USA.
  • Chu HY; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Alter G; Department of Epidemiology and.
  • Seshadri C; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
JCI Insight ; 6(6)2021 03 22.
Article in En | MEDLINE | ID: mdl-33621211
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virion / CD4-Positive T-Lymphocytes / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 / Hospitalization / Antibodies, Viral Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: JCI Insight Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virion / CD4-Positive T-Lymphocytes / Spike Glycoprotein, Coronavirus / SARS-CoV-2 / COVID-19 / Hospitalization / Antibodies, Viral Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: JCI Insight Year: 2021 Type: Article Affiliation country: United States